Southern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia
|
|
- Basil Tyler
- 7 years ago
- Views:
Transcription
1 Southern Derbyshire Shared Care Pathology Guidelines Hyperkalaemia Purpose of Guideline Dealing with adult patients with Hyperkalaemia in the community Definition Serum potassium normal range is mmol/l Importance of Hyperkalaemia Severe hyperkalemia should be treated as a medical emergency and carries the risk of a cardiac event (see below) When is hyperkalemia considered a medical emergency? Potassium mmol/l Not usually a medical emergency Potassium mmol/l Possible medical emergency Potassium 7.0 mmol/l Usually a medical emergency These limits are for guidance only; the severity of clinical effects depends not only on the potassium level but also on whether the rise is acute or chronic. In many patients if the patient has acute kidney injury they will need admission to hospital. In mild to moderate hyperkalaemia, if previous results have been similar there may be no need for urgent admission. The laboratory usually telephones all true potassium results >6.1 mmol/l, Monday to Friday when GP practices are open. When the potassium is >6.5 mmol/l the result will usually be telephoned to Derbyshire Health United when the GP practice is closed. In cases of persistent mild hyperkalaemia subsequent raised results may not be telephoned. Dependent upon other results and recent changes, potassium values between mmol/l may also be telephoned out of hours. Authorised by Julia Forsyth Page 1 of 6
2 When is hyperkalaemia suspected? Clinical symptoms of hyperkalaemia include: Arrhythmias Muscle weakness, fatigue, parathesia ECG changes (peaked T waves, widening of QRS complex) Excessive dietary intake of potassium is not normally associated with hyperkalaemia if renal function is normal as the kidneys readily excrete any excess. In General Practice hyperkalaemia is most often associated with certain drugs and renal disease. What happens next? Step 1 Could the result could be spuriously high? Result appears genuinely raised See section 1 (Page 3) for causes of artefactually raised potassium Before reporting a result the lab checks for: EDTA contamination Delayed separation of plasma from cells In vitro haemolysis High platelets or white cell count Step 2 What are the causes of true hyperkalaemia? See section 2 (Page 4) for details Consider the following: Drug Therapy Renal Function Is patient Diabetic? Step 3 Assess the clinical urgency. Suggested action is outlined in section 3 (Page 4-5) depending on: Severity of Hyperkalaemia Clinical condition of patient Authorised by Julia Forsyth Page 2 of 6
3 1. Is it correct? Pseudohyperkalaemia (artefactually increased in vitro potassium levels while the in vivo concentration is normal) is the most common reason for an isolated raised potassium result and the following causes should be considered, especially if there is no clinical evidence of hyperkalaemia. K-EDTA contamination of the sample from an FBC tube. o When using the Vacutainer system ALWAYS take the U&E (Gold Top) sample first. A small amount of contamination from the FBC Tube (Lavender Top) will lead to an artefactually raised potassium result. Delayed sample separation. o Potassium starts to rise in un-separated samples after 6 hours storage at room temperature (15º C - 25º C), and is usually unsuitable for analysis >12 hours after venepuncture if not separated from the cells. To enable the laboratory to spot this ALWAYS provide the time and date a sample is taken. Storage at cold temperatures. o At low temperatures (< 8º C) the ATPase Na-K pump becomes inactive, and there is a rapid leak of potassium out of the red blood cells. Therefore NEVER refrigerate samples. Depending how samples are transported and stored this same effect can be seen on very cold days. Thrombocytosis o Leakage of potassium from platelets during clotting and centrifugation can lead to falsely raised potassium results in patients with thrombocytopaenia. Please use a Lithium Heparin sample (Green Top) if known. Severe leucocytosis / Fragile white cells o This would be a rare cause in GP samples, but when suspected suggest telephone Duty Biochemist. Haemolysis in vitro o Difficult sample collection and inappropriate sample handling (e.g. shaking tube) can lead to haemolysis in vitro. (e.g. difficult specimen collection) Before reporting a result the lab will usually check for the possibility of contamination with EDTA, delayed separation of plasma from cells, in vitro haemolysis, high platelets or white cell count and will deal with results and give advice accordingly. Authorised by Julia Forsyth Page 3 of 6
4 2. What are the likely causes in this patient? What drugs is the patient on? The following drugs may contribute to hyperkalaemia: ACE inhibitors Angiotensin-II receptor antagonists ( sartans ) Potassium supplements Potassium sparing diuretics (spironolactone, amiloride) NSAIDs Trimethoprim Heparin Βeta-Blockers Where possible when requesting potassium please indicate if the patient is on any of the above medication, as this information is vitally useful for Pathology and Derbyshire Health United when considering if further urgent action is needed for that patient. What is the renal function? In chronic kidney disease, high potassium is not usually seen until late stage 4 or 5, but it may be much higher for the same level of creatinine in acute renal failure (Acute Kidney Injury). Does the patient have diabetic nephropathy? Potassium is often much higher in longstanding diabetes with apparently moderate renal impairment. 3. What action should be taken? The clinical urgency should be assessed as indicated by: The severity of hyperkalaemia o Not usually an emergency mmol/l o Possible emergency mmol/l o Severe and usually an emergency 7.0 mmol/l The extent of change in serum potassium and egfr if previous values available. Significant changes are o 0.5 mmol/l increase in potassium o 10% decrease in egfr Potassium > 6.0 mmol/l and presence of typical ECG features Potassium rising by > 0.5 mmol/l over 6-12 hours indicates significant risk at any absolute value Authorised by Julia Forsyth Page 4 of 6
5 The following advice makes the presumption that the hyperkalaemia is NOT spurious. Potassium mmol/l If the patient s egfr has not decreased by >10% and the rise in potassium is not recent (within 1 week) and <0.5 mmol/l, suggest repeat potassium analysis within 1 to 2 weeks. If patient is on any of the drugs listed on page 4, consider dose and/or changing therapy. In general these patients do not require emergency admission. Potassium mmol/l Any potassium result 6.1 mmol/l should be rechecked as soon as possible unless it has been previously similar. Drugs which can raise potassium (Page 4) should be stopped immediately until it has been checked. If available consider performing ECG. Consider emergency admission to hospital. Base your decision on: Clinical state of patient Presence of Arrhythmias Severe muscle weakness, paralysis, fatigue, parathesia If available, ECG changes (peaked T waves, widening of QRS complex) Rapid fall in egfr (>10% within 1-2 weeks) Rapid increase in potassium (>0.5 mmol/l within 1-2 weeks) Advice can be obtained from Consultant Phone Triage (10:00 to 18:00 Mon-Fri). Refer patients to MAU/ACC in the first instance (NOT to the Emergency Department unless the patient is acutely unwell - see contacts below). Potassium 7.0 mmol/l Patients with potassium 7.0 mmol/l usually require urgent admission to hospital. If available consider performing ECG. Refer patients either to MAU/ACC or the renal team if known renal disease (see contacts below). DO NOT refer to the Emergency Department unless the patient is acutely unwell. We have seen genuine confirmed potassium results from primary care as high as 9.5 mmol/l, so do not discount very high levels as being clinically implausible. Authorised by Julia Forsyth Page 5 of 6
6 Contacts Duty Biochemist (8am to 7pm, Monday-Friday) On Call Consultant Biochemist Via RDH switchboard, (24/7) Renal Registrar 9am to 9pm, via RDH switchboard bleep 8121 Consultant Phone Triage Via RDH switchboard, (10am to 6pm Mon-Fri) MAU and ACC OR MAU Nurse in Charge Authors: Mrs Helen Seddon, Maarten Taal, Dan Becker, Ben Pearson & Nigel Lawson November 2011 Reviewed by: Date: Expiry date: Dr D Becker, Dr P Blackwell, Mrs H Seddon Nov th Nov 2015 Dr D Becker, Dr P Blackwell, Mrs H Seddon Dec st Dec 2017 Authorised by Julia Forsyth Page 6 of 6
Southern Derbyshire Shared Care Pathology Guidelines. Vitamin D
Southern Derbyshire Shared Care Pathology Guidelines Vitamin D Purpose of guideline Provide clear advice on when to measure vitamin D and identify patients with insufficiency and deficiency. To provide
More informationGuideline for the Management of Acute Hyperkalaemia in Adults
Guideline for the Management of Acute Hyperkalaemia in Adults Author Directorate & Speciality Updated by John Gell (Clinical Pharmacist) Diagnostics and Clinical Support Date of submission April 2013 Date
More informationGuideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationSouthern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care
Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT
More informationReference Range: 0.5-1.6 mmol/l (arterial) 0.7-2.1 mmol/l (venous) CPT Code: 83605
LACTIC ACID Fasting, arterial specimen preferred. Please note whether arterial or venous. 0.5 ml heparinized plasma. Green top or PST must be drawn, placed on ice, and spun within 15 minutes. Immediately
More informationChronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1
Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have
More informationInterpretation of Laboratory Values
Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances
More informationPOAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationThe Blood Budget: how can we reduce costs and influence best practice? Sue Redfearn Blood Transfusion Manager Poole Hospital NHS Foundation Trust
The Blood Budget: how can we reduce costs and influence best practice? Sue Redfearn Blood Transfusion Manager Poole Hospital NHS Foundation Trust Poole Hospital vital statistics 680 beds 2011 (reduced
More informationVITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS
39 Chapter 3 VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS Maxine Briggs TABLE OF CONTENTS I. Review of the
More informationIdentifying and treating long-term kidney problems (chronic kidney disease)
Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for
More informationPRESCRIBING INFORMATION K-10. (Potassium Chloride Oral Solution, 10% USP) POTASSIUM REPLACEMENT THERAPY
PRESCRIBING INFORMATION K-10 (Potassium Chloride Oral Solution, 10% USP) POTASSIUM REPLACEMENT THERAPY GlaxoSmithKline Inc Date of Revision: 7333 Mississauga Road North April 14, 2015 Mississauga, OntarioL5N
More informationUniversity College Hospital. Sick day rules insulin pump therapy
University College Hospital Sick day rules insulin pump therapy Children and Young People s Diabetes Service Children whose diabetes is well controlled should not experience more illness or infections
More informationCollect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
More informationHypertension Guidelines
Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not
More informationBiochemistry Validation Form
Biochemistry Validation Form Method: Piccolo Xpress Chemistry 13 panel Manufacturer: Abaxis Cat no: 400-0029 CE marked: Yes: x No: Location of bench book: X:\Bio\Patricia\Piccollo Xpress evaluation (August
More informationCollection Guidelines for Routine & Special Coagulation Testing
Revised May 2010 Collection Guidelines for Routine & Special Coagulation Testing Best samples come from peripheral stick with evacuated tube system 19 to 22 gauge needle (smaller or bigger could cause
More informationLothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
More informationEnoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants
Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications
More informationProtocol for the safe administration of iodinated contrast media in diagnostic radiology
Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol statement: This protocol applies to all staff within Radiology Departments at Heart of England NHS Foundation
More information2. What Should Advocates Know About Diabetes? O
2. What Should Advocates Know About Diabetes? O ften a school district s failure to properly address the needs of a student with diabetes is due not to bad faith, but to ignorance or a lack of accurate
More informationJeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)
Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) I HEAR YA KNOCKING BUT YOU CAN T COME IN (electrolytes) TAKE MY BREATH AWAY (Opiates-morphine) OUT WITH
More informationThe Golden Rule of Specimen Collection: The Patient Test Result is Only as Good as the Sample We Get
The Golden Rule of Specimen Collection: The Patient Test Result is Only as Good as the Sample We Get Jan Frerichs, MLS (ASCP) The University of Iowa Janice-frerichs@uiowa.edu Importance of Phlebotomist
More informationONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
More informationKetones and Ketoacidosis
Ketones and Ketoacidosis If you have diabetes and become unwell or have high blood glucose levels of 14 mmol/l or more please check for ketones If the body does not have enough insulin its energy levels
More informationChronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
More informationCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
More informationReducing Insulin Related Errors in Patients Treated for Hyperkalemia
Reducing Insulin Related Errors in Patients Treated for Hyperkalemia Tan Tock Seng Hospital is an acute care general hospital with a 1,200 bed capacity The hospital addressed the problem of insulinrelated
More informationLaboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition
Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition Copy 1 Location of copies Web based only The following guideline is for use by medical staff caring for the patient and members
More informationPrimary Care Management of Male Lower Urinary Tract Symptoms. Matthew B.K. Shaw Consultant Urological Surgeon
Primary Care Management of Male Lower Urinary Tract Symptoms Matthew B.K. Shaw Consultant Urological Surgeon NICE LUTS Guidelines Lower Urinary Tract Symptoms (LUTS) in men. NICE Clinical Guideline 97
More informationClinical Aspects of Hyponatremia & Hypernatremia
Clinical Aspects of Hyponatremia & Hypernatremia Case Presentation: History 62 y/o male is admitted to the hospital with a 3 month history of excessive urination (polyuria) and excess water intake up to
More informationHigh Blood Pressure and Kidney Disease
High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key
More informationACID- BASE and ELECTROLYTE BALANCE. MGHS School of EMT-Paramedic Program 2011
ACID- BASE and ELECTROLYTE BALANCE MGHS School of EMT-Paramedic Program 2011 ACID- BASE BALANCE Ions balance themselves like a see-saw. Solutions turn into acids when concentration of hydrogen ions rises
More informationoptimal use of thyroid function tests (TFTs) to diagnose and monitor thyroid disease.
Guidance for Thyroid Function Testing in Primary Care in Lothian In July 2006 following a lengthy consultation process, a joint working group comprising representatives from the Association of Clinical
More informationHydration Protocol for Cisplatin Chemotherapy
Betsi Cadwaladr University Health Version: 1.3 CSPM2 Hydration Protocol for Cisplatin Chemotherapy Date to be reviewed: July 2018 No of pages: 9 Author(s): Tracy Parry-Jones Author(s) title: Lead Cancer
More informationHypertension and Heart Failure Medications. Dr William Dooley
Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:
More informationDorset Cardiac Centre
P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February
More informationHow To Test For Creatinine
Creatinine is measured amperometrically. Creatinine is hydrolyzed to creatine in a reaction catalyzed by the enzyme creatinine amidohydrolase. Creatine is then hydrolyzed to sarcosine in a reaction catalyzed
More informationBCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )
BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) Protocol Code Tumour Group Contact Physician UGIPNSUNI Gastrointestinal Dr. Hagen
More informationHigh Blood pressure and chronic kidney disease
High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney
More informationCold Agglutination Titer detecting Cold Reacting Antibodies
Objectives: Cold Agglutination Titer detecting Cold Reacting Antibodies 1. Perform a serial dilution to determine the amount of cold reacting antibody present in a patient specimen with the results obtained
More informationSPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationHigh Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4
High Blood Pressure and Chronic Kidney Disease For People With CKD Stages 1 4 National Kidney Foundation s Kidney Disease Outcomes Quality Initiative (NKF-KDOQI ) The National Kidney Foundation s Kidney
More informationGLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT)
GLUCOSE TOLERANCE TESTING GESTATIONAL DIABETIC SCREEN (GDS2) GLUCOSE TOLERANCE (FOR DIABETESMELLITUS)- NON-PREGNANT ADULT/CHILDREN (Under 18 years old) (OGTT) GLUCOSE 2-HR POST-GLUCOSE LOAD (2HGPL)-SCREEN
More informationRheumatoid Arthritis. GP workshop 15 January 2011
Rheumatoid Arthritis GP workshop 15 January 2011 Case 1 A 72 year old Malay woman with RA comes for routine follow up. She feels generally unwell in the last 5 days. Appetite is fair. Her joints are fine.
More informationHypertension Guideline V4
Hypertension Guideline V4 Approved 24/06/2008 Version VERSION 4 FINAL Date of First Issue 26/02/08 Review Date 01/03/2010 Date of Issue 24/06/2008 EQIA Yes / No 24/06/2008 Author / Contact Dr Leslie Cruickshank
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr ENTRESTO TM sacubitril/valsartan film-coated tablets Read this carefully before you start taking ENTRESTO TM and
More informationA Guide to Our Services
A Guide to Our Services Charlotte Keel Health Centre Seymour Road Easton Bristol BS5 0UA Tel: 0117 902 7145 Fax: 0117 935 4447 Web-site: v13.0.01 Welcome to Seymour Medical Practice This leaflet is a guide
More informationTeriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).
Page 1 of 10 ANALYTE NAME AND STRUCTURE TERIFLUNOMIDE Teriflunomide TRADE NAME Aubagio CATEGORY Antimetabolite TEST CODE PURPOSE Therapeutic Drug Monitoring GENERAL RELEVANCY BACKGROUND sclerosis. The
More informationInDependent Diabetes Trust
InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use
More informationA Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes
A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes 1. Summary... 1 2. Background... 2 3. Purpose 2 4. Responsibilities. 2 5. Blood Glucose Monitoring. 2 6. Resident Groups that
More informationHigh Blood Pressure and Your Kidneys
American Kidney Fund reaching out giving hope improving lives High Blood Pressure and Your Kidneys reaching out giving hope improving lives High Blood Pressure: The #2 Cause of Kidney Failure Your doctor
More informationLEFLUNOMIDE (Adults)
Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active
More informationCentral Line Blood Draw
Central Line Blood Draw Welcome to the Central Line dressing blood draw refresher. Please use the navigation below to advance to the next page. The Central Line blood draw module is also available as a
More informationThe new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationPPS UNDERWRITING GUIDE FOR APPLICANTS
PPS UNDERWRITING GUIDE FOR APPLICANTS UNDERWRITING guide 2013 WHAT HAPPENS WHEN YOU SUBMIT YOUR APPLICATION FOR INSURANCE? Once an application is submitted it is put through a number of processes to ensure
More informationCalculating the stage of Renal Disease
Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage
More informationGFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National
More informationHAEMATOLOGY LABORATORY
HAEMATOLOGY LABORATORY Head of Unit : Dr Raudhawati Osman Phone : +603-26155281 Email : raudhaosman@yahoo.com 1. INTRODUCTION The Haematology Unit, Department of Pathology, HKL provides tertiary diagnostic
More information4.2 Spinal Cord Compression
4.2 Spinal Cord Compression AO Protocol Name: Metastatic Spinal Cord Compression (MSCC) AO Type: Type I (New Cancer), Type III (Cancer Complication) Author: ST Introduction: MSCC can cause irreversible
More informationAmmonia (plasma, blood)
Ammonia (plasma, blood) 1 Name and description of analyte 1.1 Name of analyte Ammonia 1.2 Alternative names None 1.3 NLMC code 1.4 Description of analyte Ammonia has the formula NH 3. At physiological
More informationNHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation
NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation Date of First Issue 06/06/2012 Approved 06/06/2012 Current Issue Date 06/06/2012 Review Date 06/06/2014 Version 1.1 EQIA Yes /
More informationLithium initiated by Secondary Care (Mental Health) Prescribe by Brand Name (usually Priadel)
Nottinghamshire Health Community Algorithm for Prescribing and Monitoring Lithium within Primary and Secondary Care (Mental Health) Traffic Light Classification - Amber 2 Information sheet for Primary
More informationAarhus University Hospital Validation Tempus600 Transport system for blood tube samples. Pediatric blood samples
Aarhus University Hospital Validation Tempus6 Transport system for blood tube samples Pediatric blood samples Department of Clinical Biochemistry, SKS January 213 Aarhus Universitetshospital Inflammationscenteret
More informationDiabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
More informationHyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
More informationSouthern Derbyshire. Shared Care Pathology Guidelines. Abnormal Liver Function Tests (LFTs) in Adults
Southern Derbyshire Shared Care Pathology Guidelines Abnormal Liver Function Tests (LFTs) in Adults Purpose of Guideline The management of patients with abnormal liver function test results Scope This
More informationEFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
More informationTests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.
In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationNurse Aide Training Program Application Checklist
Nurse Aide Training Program Application Checklist The following checklist must be completed before enrolling in the Nurse Aide Training course: Complete, sign, and date the Application Form Have the physical
More informationCongestive Heart Failure
Healthy People 2010 Conference Health Education on the Internet Welcome Mr. System Administrator Congestive Heart Failure What is congestive heart failure? How does it occur? What are the symptoms? How
More informationProvided by the American Venous Forum: veinforum.org
CHAPTER 1 NORMAL VENOUS CIRCULATION Original author: Frank Padberg Abstracted by Teresa L.Carman Introduction The circulatory system is responsible for circulating (moving) blood throughout the body. The
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
More informationStandard Operating Procedure (SOP) Work Package 8. Sample Collection and Storage
Standard Operating Procedure (SOP) Work Package 8 Sample Collection and Storage May 2008 SOP WP 8 - Sample collection Table of Contents 1 SAMPLE COLLECTION... 3 1.1 Sample collection -summary... 3 1.2
More informationHigh Blood Pressure and Your Kidneys
High Blood Pressure and Your Kidneys About 65 million Americans have high blood pressure, but as many as one third or three in 10 don't even know it. There are usually no signs or symptoms that your blood
More informationADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
More informationPlanning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation
Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent
More informationLung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)
Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed
More informationPPP 1. Continuation of a medication to ensure continuity of care
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationInformation Pathway. Myeloma tests and investigations. Paraprotein measurement
Information Pathway Myeloma UK Broughton House 31 Dunedin Street Edinburgh EH7 4JG Tel: + 44 (0) 131 557 3332 Fax: + 44 (0) 131 557 9785 Myeloma Infoline 0800 980 3332 www.myeloma.org.uk Charity No. SC
More informationAlbumin. Prothrombin time. Total protein
Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis
More informationCase Study 6: Management of Hypertension
Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular
More informationAmylase and Lipase Tests
Amylase and Lipase Tests Also known as: Amy Formal name: Amylase Related tests: Lipase The Test The blood amylase test is ordered, often along with a lipase test, to help diagnose and monitor acute or
More informationEpidural Continuous Infusion. Patient information Leaflet
Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as
More informationSafety and efficacy of bariatric surgery in obese patients with CKD: the London Renal Obesity Network (LonRON) experience
Safety and efficacy of bariatric surgery in obese patients with CKD: the London Renal Obesity Network (LonRON) experience Helen L MacLaughlin, Iain C Macdougall, Ahmed Ahmed, Ameet G Patel, Avril Chang,
More informationSHARED CARE GUIDELINE FOR LITHIUM. 1. Aim/Purpose of this Guideline. 2. The Guidance
SHARED CARE GUIDELINE FOR LITHIUM 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of lithium.
More informationTackling the Semantic Interoperability challenge
European Patient Summaries: What is next? Tackling the Semantic Interoperability challenge Dipak Kalra Cross-border health care The context for sharing health summaries Also useful for within-border health
More informationNHS FORTH VALLEY B12 and Folate: A Practical Guide
NHS FORTH VALLEY B12 and Folate: A Practical Guide Date of First Issue 27/05/2011 Approved 28/06/2011 Current Issue Date 24/06/2013 Review Date 24/06/2015 Version 1.0 EQIA 27/05/2011 Author / Contact Group
More informationNHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation
NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation Date of First Issue 06/06/2012 Approved 06/06/2012 Current Issue Date 29/10/2014 Review Date 29/10/2016 Version 1.4 EQIA Yes 01/06/2012
More informationChronic Kidney Disease
Page 1 of 6 Chronic Kidney Disease Chronic kidney disease (CKD) means that your kidneys are not working as well as they once did. Various conditions can cause CKD. Severity can vary but most cases are:
More informationNegative Pressure Wound Therapy (VAC Therapy) Guidelines
Negative Pressure Wound Therapy (VAC Therapy) Guidelines This is a living document and will be updated as required March 2013 Negative Pressure Wound Therapy Negative Pressure Wound Therapy (NPWT), also
More informationPeritoneal dialysis all you need to know about your blood results
Peritoneal dialysis all you need to know about your blood results Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationINTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline
Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative
More informationCorCap Cardiac Support Device Patient Information Booklet
What is Heart Failure? CorCap Cardiac Support Device Patient Information Booklet Heart failure is a condition in which the heart is unable to pump enough blood to meet the needs of the body. To compensate
More information